KineMed, Inc. Announces an Agreement With MedImmune (AZN) to Study Protein Dynamics Related to Neurodegenerative Diseases
5/21/2013 10:09:08 AM
More...
|
KineMed, Inc. Release: Connecting Biomarkers With Clinical Symptoms and Neuronal Dysfunction in Brain Disorders
3/13/2013 9:00:28 AM
More...
|
Huntington's Disease Therapeutic and Companion Biomarker Collaboration Forged by KineMed, Inc., Isis Pharmaceuticals, Inc. (ISIS), and CHDI, Inc.
2/21/2013 9:18:01 AM
More...
|
KineMed, Inc. Release: The First Functionally Interpretable Systems Biology Platform for Personalized Medicine and Drug Development
1/3/2013 9:48:14 AM
More...
|
KineMed, Inc. Receives Enabling Technology Award for Pathway Based Drug Discovery From Frost & Sullivan
11/13/2012 9:31:49 AM
More...
|
Pairing Diagnostics With Therapeutics: KineMed, Inc. to Present Biomarker Solutions for Personalized Medicine at the 2012 Biotechnology Industry Organization (BIO) Investor Forum
10/3/2012 10:05:36 AM
More...
|
KineMed, Inc. to Present Ground-Breaking Human Biomarker Data for the Diagnosis and Treatment of Parkinson’s Disease
9/11/2012 10:10:10 AM
More...
|
KineMed, Inc. Release: Parkinson's Brain Chemistry Changes Now Trackable in Man
9/10/2012 9:26:19 AM
More...
|
KineMed, Inc. to Present “Proteome Dynamics: Measuring the Kinetics of Complex Networks in Cardiometabolic Disease” at the 2012 Kern Lipid Conference in Vail, Colorado
7/11/2012 9:53:41 AM
More...
|
KineMed, Inc. Announces Biomarker Discovery Collaboration With GlaxoSmithKline (GSK)
6/18/2012 7:50:00 AM
More...
|
|